Trial intelligence / Profile preview

Decitabine and Genistein in Pediatric Relapsed/Refractory Solid Tumors and Leukemia

NCT02499861Phase 2Completed

Sponsor
Centre Hospitalier Universitaire Sainte-Justine
Start
Jul 2015
Primary completion
Oct 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of decitabine, genistein in solid tumor, leukemia, sponsored by Centre Hospitalier Universitaire Sainte-Justine. Started Jul 2015; status: completed.

02

Drugs

decitabinegenistein
03

Conditions

solid tumorleukemia

Beyond the preview

Go deeper on NCT02499861.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02499861.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call